Clinical value of whole-body PET/CT in patients with active rheumatic diseases

Arthritis Research and Therapy

Volumn 16, Issue 5, 2014, Pages

  Yamashita, Hiroyuki ^a   Kubota, Kazuo ^a   Mimori, Akio ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT ONSET STILL DISEASE; DERMATOMYOSITIS; DIAGNOSTIC IMAGING; DISEASE SEVERITY; EARLY DIAGNOSIS; HUMAN; IMMUNOGLOBULIN G4 RELATED DISEASE; INFLAMMATORY DISEASE; LARGE VESSEL VASCULITIS; POLYMYOSITIS; RELAPSING POLYCHONDRITIS; REVIEW; RHEUMATIC DISEASE; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SPONDYLARTHRITIS; TREATMENT RESPONSE; WEGENER GRANULOMATOSIS; WHOLE BODY CT; WHOLE BODY PET; CLASSIFICATION; COMPUTER ASSISTED TOMOGRAPHY; MULTIMODAL IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; REPRODUCIBILITY; RHEUMATIC DISEASES; SENSITIVITY AND SPECIFICITY;

EARLY DIAGNOSIS; FLUORODEOXYGLUCOSE F18; HUMANS; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; RHEUMATIC DISEASES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84906822471     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-014-0423-2     Document Type: Review

References (54)

1. Landewe´ RB, Boers M, Verhoeven AC, Westhovens R, van de Laar MA, Markusse HM, van Denderen JC, Westedt ML, Peeters AJ, Dijkmans BA, Jacobs P, Boonen A, van der Heijde DM, van der Linden S. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002, 46:347-356. 10.1002/art.10083, 11840436.
2. Ostergaard M, Hansen M, Stoltenberg M, Gideon P, Klarlund M, Jensen KE, Lorenzen I. Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis Rheum 1999, 42:918-929. 10.1002/1529-0131(199905)42:5<918::AID-ANR10>3.0.CO;2-2, 10323447.
3. Kane D, Balint PV, Sturrock RD. Ultrasonography is superior to clinical examination in the detection and localization of knee joint effusion in rheumatoid arthritis. J Rheumatol 2003, 30:966-971. 12734890.
4. Koenigkam-Santos M, Sharma P, Kalb B, Oshinski JN, Weyand CM, Goronzy JJ, Martin DR. Magnetic resonance angiography in extracranial giant cell arteritis. J Clin Rheumatol 2011, 17:306-310. 10.1097/RHU.0b013e31822acec6, 21869711.
5. Denko N. Hypoxia, HIF1 and glucose metabolism in the solid tumor. Nature Rev Cancer 2008, 8:705-713. 10.1038/nrc2468.
6. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of flurine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992, 33:1972-1980. 1432158.
7. Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995, 36:1301-1306. 7790960.
8. Cramer T, Yamanishi Y, Clausen BE, Fo¨rster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, Firestein GS, Gerber HP, Ferrara N, Johnson RS. HIF-1α is essential for myeloid cell-mediated inflammation. Cell 2003, 112:645-657. 10.1016/S0092-8674(03)00154-5, 12628185.
9. Matsui T, Nakata N, Nagai S, Nakatani A, Takahashi M, Momose T, Ohtomo K, Koyasu S. Inflammatory cytokines and hypoxia contribute to 18F-FDG uptake by cells involved in pannus formation in rheumatoid arthritis. J Nucl Med 2009, 50:920-926. 10.2967/jnumed.108.060103, 19443596.
10. Palmer WE, Rosenthal DI, Schoenberg OI, Fischman AJ, Simon LS, Rubin RH, Polisson RP. Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1995, 196:647-655. 10.1148/radiology.196.3.7644624, 7644624.
11. Beckers C, Ribbens C, Andre´ B, Marcelis S, Kaye O, Mathy L, Kaiser MJ, Hustinx R, Foidart J, Malaise MG. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med 2004, 45:956-964. 15181130.
12. Kubota K, Ito K, Morooka M, Mitsumoto T, Kurihara K, Yamashita H, Takahashi Y, Mimori A. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints. Ann Nucl Med 2009, 23:783-791. 10.1007/s12149-009-0305-x, 19834653.
13. Goerres GW, Forster A, Uebelhart D, Seifert B, Treyer V, Michel B, von Schulthess GK, Kaim AH. F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis. Clin Nucl Med 2006, 31:386-390. 10.1097/01.rlu.0000222678.95218.42, 16785804.
14. Okamura K, Yonemoto Y, Arisaka Y, Takeuchi K, Kobayashi T, Oriuchi N, Tsushima Y, Takagishi K. The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT. Rheumatology (Oxford) 2012, 51:1484-1491. 10.1093/rheumatology/kes064.
15. Elzinga EH, van der Laken CJ, Comans EF, Lammertsma AA, Dijkmans BA, Voskuyl AE. 2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis. Molecular Imaging Biology 2007, 9:357-360. 10.1007/s11307-007-0113-4, 17902022.
16. Ostendorf B, Mattes-Gyo¨rgy K, Reichelt DC, Blondin D, Wirrwar A, Lanzman R, Mu¨ller HW, Schneider M, Mo¨dder U, Scherer A. Early detection of bony alterations in rheumatoid and erosive arthritis of finger joints with high-resolution single photon emission computed tomography, and differentiation between them. Skeletal Radiol 2010, 39:55-61. 10.1007/s00256-009-0761-3, 19669137.
17. Okabe T, Shibata H, Shizukuishi K, Yoneyama T, Inoue T, Tateishi U. F-18 FDG uptake patterns and disease activity of collagen vascular diseases-associated arthritis. Clin Nucl Med 2011, 36:350-354. 10.1097/RLU.0b013e318212c858, 21467850.
18. Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 2008, 58:2958-2967. 10.1002/art.23945, 18821687.
19. Elzinga EH, van der Laken CJ, Comans EF, Boellaard R, Hoekstra OS, Dijkmans BA, Lammertsma AA, Voskuyl AE. 18F-FDG PET as a tool to predict the clinical outcome of infliximab treatment of rheumatoid arthritis: an explorative study. J Nucl Med 2011, 52:77-80. 10.2967/jnumed.110.076711, 21149486.
20. Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol 2010, 195:310-320. 10.2214/AJR.10.4923, 20651185.
21. Szkudlarek M, Court P, Jacobsen S, Klarlund M, Thomsen HS, Ostergaard M. Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis Rheum 2003, 48:955-962. 10.1002/art.10877, 12687537.
22. Kubota K, Ito K, Morooka M, Minamimoto R, Miyata Y, Yamashita H, Takahashi Y, Mimori A. FDG PET for rheumatoid arthritis: basic considerations and whole-body PET/CT. Ann N Y Acad Sci 2011, 1228:29-38. 10.1111/j.1749-6632.2011.06031.x, 21718320.
23. Miese F, Scherer A, Ostendorf B, Heinzel A, Lanzman RS, Kro¨pil P, Blondin D, Hautzel H, Wittsack HJ, Schneider M, Antoch G, Herzog H, Shah NJ. Hybrid 18F-FDG PET-MRI of the hand in rheumatoid arthritis: initial results. Clin Rheumatol 2011, 30:1247-1250. 10.1007/s10067-011-1777-3, 21590292.
24. Yamashita H, Kubota K, Takahashi Y, Minamimoto R, Morooka M, Kaneko H, Kano T, Mimori A. Similarities and differences in fluorodeoxyglucose positron emission tomography/computed tomography findings in spondyloarthropathy, polymyalgia rheumatica and rheumatoid arthritis. Joint Bone Spine 2013, 80:171-177. 10.1016/j.jbspin.2012.04.006, 22749663.
25. Nash P, Mease PJ, Braun J, van der Heijde D. Seronegative spondyloarthropathies: to lump or split?. Ann Rheum Dis 2005, 64:9-13.
26. Godfrin B, Zabraniecki L, Lamboley V, Bertrand-Latour F, Sans N, Fournie´ B. Spondyloarthropathy with entheseal pain. A prospective study in 33 patients. Joint Bone Spine 2004, 71:557-562. 10.1016/j.jbspin.2003.10.010, 15589439.
27. Taniguchi Y, Arii K, Kumon Y, Fukumoto M, Ohnishi T, Horino T, Kagawa T, Kobayashi S, Ogawa Y, Terada Y. Positron emission tomography/computed tomography: a clinical tool for evaluation of enthesitis in patients with spondyloarthritides. Rheumatology (Oxford) 2010, 49:348-354. 10.1093/rheumatology/kep379.
28. Strobel K, Fischer DR, Tamborrini G, Kyburz D, Stumpe KD, Hesselmann RG, Johayem A, von Schulthess GK, Michel BA, Ciurea A. 18F-fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis. Eur J Nucl Med Mol Imaging 2010, 37:1760-1765. 10.1007/s00259-010-1464-7, 20505935.
29. Vijayant V, Sarma M, Aurangabadkar H, Bichile L, Basu S. Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies. World J Radiol 2012, 4:462-468. 10.4329/wjr.v4.i12.462, 23320137.
30. Yamashita H, Kubota K, Takahashi Y, Minaminoto R, Morooka M, Ito K, Kano T, Kaneko H, Takashima H, Mimoiri A. Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis. Mod Rheumatol 2012, 22:705-711. 10.3109/s10165-011-0581-x, 22205118.
31. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982, 97:672-680. 10.7326/0003-4819-97-5-672, 6982645.
32. Healey LA. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum 1984, 13:322-328. 10.1016/0049-0172(84)90012-X, 6729485.
33. Salvarani C, Cantini F, Olivieri I, Hunder GS. Polymyalgia rheumatica: a disorder of extraarticular synovial structures?. J Rheumatol 1999, 26:517. 10090155.
34. Salvarani C, Cantini F, Olivieri I, Barozzi L, Macchioni L, Niccoli L, Padula A, De Matteis M, Pavlica P. Proximal bursitis in active polymyalgia rheumatica. Ann Intern Med 1997, 127:27. 10.7326/0003-4819-127-1-199707010-00005, 9214249.
35. Cantini F, Salvarani C, Olivieri I, Niccoli L, Padula A, Macchioni L, Boiardi L, Ciancio G, Mastrorosato M, Rubini F, Bozza A, Zanfranceschi G. Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study. J Rheumatol 2001, 28:1049. 11361188.
36. Moosig F, Czech N, Mehl C, Henze E, Zeuner RA, Kneba M, Schro¨der JO. Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study. Ann Rheum Dis 2004, 63:870-873. 10.1136/ard.2003.011692, 15194587.
37. Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology (Oxford) 2007, 46:672-677. 10.1093/rheumatology/kel376.
38. Yamashita H, Kubota K, Takahashi Y, Minamimoto R, Morooka M, Kaneko H, Kano T, Mimori A. Clinical value of 18F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literature. Mod Rheumatol 2014, 24:645-650. 10.3109/14397595.2013.850998, 24252024.
39. Yamashita H, Takahashi H, Kubota K, Ueda Y, Ozaki T, Yorifuji H, Bannai E, Minamimoto R, Morooka M, Miyata Y, Okasaki M, Takahashi Y, Kaneko H, Kano T, Mimori A. Utility of fluorodeoxyglucose positron emission tomography/computed tomography for early diagnosis and evaluation of disease activity of relapsing polychondritis: a case series and literature review. Rheumatology (Oxford) 2014, 53:1482-1490. 10.1093/rheumatology/keu147.
40. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota K, Yoshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Nakamura S, Inoue D. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 2012, 22:1-14. 10.3109/s10165-011-0508-6, 21881964.
41. Shigekawa M, Yamao K, Sawaki A, Hara K, Takagi T, Bhatia V, Nishio M, Tamaki T, El-Amin H, Sayed Z-A, Mizuno N. Is 18F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis?. J Hepatobiliary Pancreat Sci 2010, 17:269-274. 10.1007/s00534-009-0172-9, 19727541.
42. Ozaki Y, Oguchi K, Hamano H, Arakura N, Muraki T, Kiyosawa K, Momose M, Kadoya M, Miyata K, Aizawa T, Kawa S. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. J Gastroenterol 2008, 43:144-151. 10.1007/s00535-007-2132-y, 18306988.
43. Ebbo M, Grados A, Guedj E, Gobert D, Colavolpe C, Zaidan M, Masseau A, Bernard F, Berthelot JM, Morel N, Lifermann F, Palat S, Haroche J, Mariette X, Godeau B, Bernit E, Costedoat-Chalumeau N, Papo T, Hamidou M, Harle´ JR, Schleinitz N. 18F-FDG PET/CT for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthritis Care Res (Hoboken) 2014, 66:86-96. 10.1002/acr.22058.
44. Takahashi H, Yamashita H, Morooka M, Kubota K, Takahashi Y, Kaneko H, Kano T, Mimori A. The utility of FDG-PET/CT and other imaging techniques in the evaluation of IgG4-related disease. Joint Bone Spine 2014, 81:331-336. 10.1016/j.jbspin.2014.01.010, 24568886.
45. Muto G, Yamashita H, Takahashi Y, Miyata Y, Morooka M, Minamimoto R, Kubota K, Kaneko H, Kano T, Mimori A: Large-vessel vasculitis in elderly patients: early diagnosis and steroid-response evaluation with FDG-PET/CT and contrast-enhanced CT. Rheumatol Int 2014. Mar 19 [Epub ahead of print].
46. Treglia G, Mattoli MV, Leccisotti L, Ferraccioli G, Giordano A. Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review. Clin Rheumatol 2011, 30:1265-1275. 10.1007/s10067-011-1828-9, 21833685.
47. Ito K, Minamimoto R, Yamashita H, Yoshida S, Morooka M, Okasaki M, Mimori A, Kubota K. Evaluation of Wegener's granulomatosis using 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Ann Nucl Med 2013, 27:209-216. 10.1007/s12149-012-0675-3, 23242952.
48. Ozmen O, Tatci E, Gokcek A, Koksal D, Dadali Y, Ozaydin E, Arslan N. Integration of 2-deoxy-2-[18F] fluoro-D-glucose PET/CT into clinical management of patients with Wegener's granulomatosis. Ann Nucl Med 2013, 27:907-915. 10.1007/s12149-013-0769-6, 24037685.
49. Owada T, Maezawa R, Kurasawa K, Okada H, Arai S, Fukuda T. Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis. J Rheumatol 2012, 39:1659-1665. 10.3899/jrheum.111597, 22753657.
50. Tanaka S, Ikeda K, Uchiyama K, Iwamoto T, Sanayama Y, Okubo A, Nakagomi D, Takahashi K, Yokota M, Suto A, Suzuki K, Nakajima H. [18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis. Rheumatology (Oxford) 2013, 52:1271-1278. 10.1093/rheumatology/ket112.
51. Beckers C, Jeukens X, Ribbens C, Andre´ B, Marcelis S, Leclercq P, Kaiser MJ, Foidart J, Hustinx R, Malaise MG. (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. Eur J Nucl Med Mol Imaging 2006, 33:275-280. 10.1007/s00259-005-1952-3, 16247604.
52. Sato M, Inubushi M, Shiga T, Hirata K, Okamoto S, Kamibayashi T, Tanimura K, Tamaki N. Therapeutic effects of acupuncture in patients with rheumatoid arthritis: a prospective study using (18)F-FDG-PET. Ann Nucl Med 2009, 23:311-316. 10.1007/s12149-009-0238-4, 19337783.
53. Polisson RP, Schoenberg OI, Fischman A, Rubin R, Simon LS, Rosenthal D, Palmer WE. Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:819-825. 10.1002/art.1780380616, 7779126.
54. van Dongen GA, Visser GW, Lub-de Hooge MN, De Vries EG, Perk LR. Immuno-PET: a navigator in monoclonal antibody development and applications. Oncologist 2007, 12:1379-1389. 10.1634/theoncologist.12-12-1379, 18165614.